Study for Evaluation of Newly Onset Chest Pain and Rapid Diagnosis of Myocardial Necrosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1818 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-01

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a national multi-center, prospective surveillance study in patients with suspected acute coronary syndrome. Eligible patients must present to one of the participating Emergency Departments within 24 hours from the time of symptom onset. Approximately 2000 patients \>18 and \<85 years of age are planned to be enrolled.

Upon enrollment in the Emergency Department, a venous blood sample will be obtained from each patient for analysis. The patient's diagnostic work-up, treatment and disposition will continue per the standards of the treating institution. Results will be recorded for ECGs, any cardiac biomarkers measured at the site and any follow-up cardiac objective tests performed for evidence of coronary artery disease and/or myocardial damage (exercise treadmill, coronary angiography, cardiac thallium or technetium scintigraphy, etc).

The Principal Investigator at each site will evaluate the results of the diagnostic cardiac tests performed for that patient to determine whether each patient enrolled at their site has a final diagnosis of ACS.

The status of each patient will also be assessed at 1 month and 6 months after enrollment for intercurrent Major Adverse Cardiac Events (MACE), including myocardial infarction, cardiac revascularization and death.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Rapid Assessment of Potential Ischaemic Heart Disease With CTCA

NCT02284191

Acute Coronary Syndrome

COMPLETED NA

MRI Evaluation of Chest Pain

NCT00001961

Chest Pain Coronary Disease Myocardial Infarction

COMPLETED PHASE2

Computed Tomography Coronary Angiogram (CTCA) Versus Traditional Care in Emergency Department Assessment of Potential Acute Coronary Syndromes (ACS)

NCT00933400

Chest Pain Acute Coronary Syndrome Acute Myocardial Infarction +1 more

COMPLETED NA

Study of Coronary Artery Computed Tomography to Diagnose Emergency Chest Pain

NCT00273832

Chest Pain Angina Pectoris Myocardial Infarction

COMPLETED PHASE2

Clinical Decision Support System to Define 30 Day Adverse Clinical Events for Emergency Department Acute Coronary Syndromes

NCT03286491

Acute Coronary Syndrome Clinical Decision Support System

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Myocardial Infarction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Only patients who are able to give consent. This has to be carefully verified in each case, by the doctors leading the study
* Men or women \>18 and \<85 years of age
* Patients with chest discomfort within last 24h and suspected Acute Coronary Syndrome (STEMI, NSTEMI and unstable angina)
* Patient experiencing at least 30 minutes of chest discomfort or other symptoms consistent with possible ACS; (Note: Patients who have symptoms of shorter duration that resolved due to pharmacologic intervention may be included.)
* Written informed consent

Exclusion Criteria

* Age \<18 or \>85 years
* Inpatient in the hospital prior to onset of symptoms.
* Obvious traumatic disease
* Prisoners or other institutionalized or vulnerable individuals
* Major surgery within last 4 weeks
* Patients with cardiogenic shock
* Other significant laboratory abnormalities that the investigator feels may compromise the patient's safety by participation in the study
* Women who are pregnant or breast feeding
* Obvious iv drug abuse
* Refusal to provide written informed consent
* Unavailability of a telephone number and insufficient contact information as well as permanent residence abroad
* Unreliability as a study participant as based on the investigator's prior knowledge of the patient, such as the inability or willingness to participate in or complete the study or the presence of concurrent physical or psychological disorders that may make it impractical for the patient to participate in or complete the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No